AR043515A1 - Procedimiento para preparar derivados quirales beta aminoacidos mediante hidrogenacion asimetrica - Google Patents
Procedimiento para preparar derivados quirales beta aminoacidos mediante hidrogenacion asimetricaInfo
- Publication number
- AR043515A1 AR043515A1 ARP040100745A ARP040100745A AR043515A1 AR 043515 A1 AR043515 A1 AR 043515A1 AR P040100745 A ARP040100745 A AR P040100745A AR P040100745 A ARP040100745 A AR P040100745A AR 043515 A1 AR043515 A1 AR 043515A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- aryl
- ring system
- structural formula
- heterocyclic ring
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2282—Unsaturated compounds used as ligands
- B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/16—Preparation of optical isomers
- C07C231/18—Preparation of optical isomers by stereospecific synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/60—Reduction reactions, e.g. hydrogenation
- B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
- B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
- B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
- B01J2531/0261—Complexes comprising ligands with non-tetrahedral chirality
- B01J2531/0263—Planar chiral ligands, e.g. derived from donor-substituted paracyclophanes and metallocenes or from substituted arenes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
- B01J2531/0286—Complexes comprising ligands or other components characterized by their function
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/822—Rhodium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/84—Metals of the iron group
- B01J2531/842—Iron
Abstract
La presente se refiere a un procedimiento para la preparación eficiente de derivados beta aminoácidos enantioméricamente enriquecidos que son útiles en la síntesis asimétrica de moléculas biológicamente activas. Reivindicación 1: Un procedimiento para preparar un compuesto de fórmula estructural (1) que tiene la configuración ( R ) o (S) en el centro estereogénico marcado con un *; en un exceso enantiomérico de al menos un 70% por encima del enantiómero opuesto, en el que Z es OR2, SR2, o NR2R3; R1 es alquilo C1-8, arilo, heteroarilo, alquil C1-2-arilo, o alquil C1-2-heteroarilo; R2 y R3 son cada uno independientemente H, alquilo C1-8, arilo, o alquil C1-2-arilo, o R2 y R3 conjuntamente con el átomo de N al cual están unidos forman un sistema anular heterocíclico de 4 a 7 miembros que contiene opcionalmente un heteroátomo adicional seleccionado de O, S, y alquilo C1-4 N, estando dicho sistema anular heterocíclico condensado opcionalmente con un sistema anillo carbocíclico de 5 a 6 miembros saturado o aromático o un sistema anillo heterocíclico de 5 a 6 miembros saturado o aromático que contiene uno o dos heteroátomos seleccionados de O, S, y alquilo C1-4N, estando dicho sistema anillo fusionado no sustituido o sustituido con uno o dos sustituyentes seleccionados independientemente de hidroxi, amino, F, alquilo C1-4, alcoxi C1-4, y trifluorometilo; que comprende la etapa de hidrogenar una enamina proquiral de fórmula estructural (2) en un disolvente orgánico adecuado en presencia de un metal de transición precursor complejado con un ligando quiral ferrocenil difosfina de fórmula estructural (3) en la que R4 es alquilo C1-4 o arilo; R5 y R6 son cada uno de ellos independientemente alquilo C1-6, cicloalquilo C5-12, o arilo; y R7 es alquilo C1-4 o fenilo no sustituido.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45593203P | 2003-03-19 | 2003-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043515A1 true AR043515A1 (es) | 2005-08-03 |
Family
ID=33098076
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040100745A AR043515A1 (es) | 2003-03-19 | 2004-03-09 | Procedimiento para preparar derivados quirales beta aminoacidos mediante hidrogenacion asimetrica |
ARP090102853A AR072877A2 (es) | 2003-03-19 | 2009-07-27 | Una forma cristalina de (2r) -4-oxo-4-[3- (trifluorometil ) -5,6-dihidro -.[1,2,4 ] - triazolo [4,3-a ] pirazin-7 (8h ) -il] -1- (2,4,5,-trifluoro fenil ) butan -2-amina |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090102853A AR072877A2 (es) | 2003-03-19 | 2009-07-27 | Una forma cristalina de (2r) -4-oxo-4-[3- (trifluorometil ) -5,6-dihidro -.[1,2,4 ] - triazolo [4,3-a ] pirazin-7 (8h ) -il] -1- (2,4,5,-trifluoro fenil ) butan -2-amina |
Country Status (12)
Country | Link |
---|---|
US (1) | US7468459B2 (es) |
EP (1) | EP1606243B1 (es) |
JP (3) | JP4503594B2 (es) |
CN (1) | CN100339354C (es) |
AR (2) | AR043515A1 (es) |
AT (1) | ATE400545T1 (es) |
AU (2) | AU2004223885B2 (es) |
CA (1) | CA2518435C (es) |
DE (1) | DE602004014910D1 (es) |
ES (1) | ES2307000T3 (es) |
TW (1) | TWI312772B (es) |
WO (1) | WO2004085378A1 (es) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1386901B1 (en) * | 2002-07-30 | 2015-07-01 | Takasago International Corporation | Method for producing an optically active beta-amino acid |
WO2005028419A2 (en) * | 2003-09-18 | 2005-03-31 | Takasago International Corporation | Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives |
EP1593671A1 (en) * | 2004-03-05 | 2005-11-09 | Graffinity Pharmaceuticals AG | DPP-IV inhibitors |
TW200602293A (en) * | 2004-04-05 | 2006-01-16 | Merck & Co Inc | Process for the preparation of enantiomerically enriched beta amino acid derivatives |
WO2006065826A2 (en) * | 2004-12-15 | 2006-06-22 | Merck & Co., Inc. | Process to chiral beta amino acid derivatives by asymmetric hydrogenation |
DOP2006000008A (es) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
AR052879A1 (es) * | 2005-01-24 | 2007-04-11 | Merck & Co Inc | Procedimiento para preparar derivados de beta aminoacidos quirales por hidrogenacion asimetrica |
US20090156465A1 (en) | 2005-12-30 | 2009-06-18 | Sattigeri Jitendra A | Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
US8466318B2 (en) | 2006-05-18 | 2013-06-18 | Boehringer Ingelheim International Gmbh | Method of preparing chiral cyclic β-aminocarboxamides |
EP1903027A1 (en) * | 2006-09-13 | 2008-03-26 | Novartis AG | Process for preparing biaryl substituted 4-amino-butyric acid or derivatives thereof and their use in the production of NEP inhibitors |
JP5450056B2 (ja) * | 2007-03-19 | 2014-03-26 | 武田薬品工業株式会社 | アリルアミン不斉水素化法 |
WO2008141021A1 (en) | 2007-05-08 | 2008-11-20 | Concert Pharmaceuticals, Inc. | Deuterated derivatives of tetrahydrotriazolopyrazine compounds and their use as dpp-iv inhibitors |
WO2009084024A2 (en) * | 2007-11-02 | 2009-07-09 | Glenmark Generics Limited | A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof |
EP2220093A4 (en) | 2007-12-20 | 2011-06-22 | Reddys Lab Ltd Dr | METHOD FOR THE PRODUCTION OF SITAGLIPTIN AND PHARMACEUTICAL ACCEPTABLE SALTS THEREOF |
EP2146210A1 (en) | 2008-04-07 | 2010-01-20 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY |
EP2381772B1 (en) | 2008-12-31 | 2016-08-24 | Chiral Quest, Inc. | Process and intermediates for the preparation of n-acylated-4-aryl beta-amino acid derivatives |
EP2223923A1 (en) | 2009-02-25 | 2010-09-01 | Esteve Química, S.A. | Process for the preparation of a chiral beta aminoacid derivative and intermediates thereof |
JP5707344B2 (ja) | 2009-02-26 | 2015-04-30 | コデクシス, インコーポレイテッド | トランスアミナーゼ生体触媒 |
EP2398803A2 (en) | 2009-03-30 | 2011-12-28 | Teva Pharmaceutical Industries Ltd. | Solid state forms of sitagliptin salts |
NZ596713A (en) | 2009-05-11 | 2014-10-31 | Generics Uk Ltd | Sitagliptin synthesis |
EP2446026B1 (en) | 2009-06-22 | 2017-08-09 | Codexis, Inc. | Transaminase reactions |
AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
CN102030683B (zh) * | 2009-09-27 | 2013-07-31 | 浙江九洲药业股份有限公司 | 西他列汀中间体及其制备方法和用途 |
KR101222679B1 (ko) * | 2009-10-21 | 2013-01-16 | 한미사이언스 주식회사 | 시타글립틴의 제조 방법 및 이에 사용되는 중간체 |
CN102093245B (zh) * | 2009-12-14 | 2015-04-15 | 浙江海翔药业股份有限公司 | 一种西他列汀中间体、西他列汀或其盐的制备方法 |
CZ303113B6 (cs) | 2010-03-16 | 2012-04-11 | Zentiva, K.S. | Zpusob prípravy sitagliptinu |
EP2547682A1 (en) | 2010-03-31 | 2013-01-23 | Teva Pharmaceutical Industries Ltd. | Solid state forms of sitagliptin salts |
CN102918027A (zh) | 2010-04-06 | 2013-02-06 | 艾尼纳制药公司 | Gpr119受体调节剂和对与所述受体有关的障碍的治疗 |
US8765668B2 (en) | 2010-06-04 | 2014-07-01 | Lek Pharmaceuticals D.D. | Methods of synthesis of β-aminobutyryl substituted compounds |
EP2392575A1 (en) | 2010-06-04 | 2011-12-07 | LEK Pharmaceuticals d.d. | A novel synthetic approach to ß-aminobutyryl substituted compounds |
EP2397141A1 (en) | 2010-06-16 | 2011-12-21 | LEK Pharmaceuticals d.d. | Process for the synthesis of beta-amino acids and derivatives thereof |
EP2423178A1 (en) | 2010-07-28 | 2012-02-29 | Chemo Ibérica, S.A. | Process for the production of sitagliptin |
US8932836B2 (en) | 2010-08-16 | 2015-01-13 | Codexis, Inc. | Biocatalysts and methods for the synthesis of (1R,2R)-2-(3,4-dimethoxyphenethoxy)cyclohexanamine |
US9179188B2 (en) * | 2010-08-30 | 2015-11-03 | Sony Corporation | Transmission apparatus and method, reception apparatus and method, and transmission and reception system |
IN2010DE02164A (es) | 2010-09-13 | 2015-07-24 | Panacea Biotec Ltd | |
AU2011305525B2 (en) | 2010-09-22 | 2016-08-18 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
WO2012042534A2 (en) * | 2010-09-28 | 2012-04-05 | Glenmark Generics Limited | Processes for the preparation of r-sitagliptin and intermediates thereof |
US20140018371A1 (en) | 2011-04-01 | 2014-01-16 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
EP2508506A1 (en) | 2011-04-08 | 2012-10-10 | LEK Pharmaceuticals d.d. | Preparation of sitagliptin intermediates |
US20140066369A1 (en) | 2011-04-19 | 2014-03-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
ITMI20110765A1 (it) | 2011-05-05 | 2012-11-06 | Chemo Iberica Sa | Processo per la produzione di sitagliptina |
US8524936B2 (en) | 2011-05-18 | 2013-09-03 | Milan Soukup | Manufacturing process for sitagliptin from L-aspartic acid |
EP2527320A1 (en) | 2011-05-27 | 2012-11-28 | LEK Pharmaceuticals d.d. | Preparation of Sitagliptin Intermediates |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
CN102260268B (zh) * | 2011-06-19 | 2013-04-03 | 漆又毛 | 苄硫基乙酰胺基乙酰吡嗪三唑衍生物及制备与应用 |
US9587229B2 (en) | 2011-06-24 | 2017-03-07 | Merck Sharp & Dohme Corp. | Immobilized transaminases and process for making and using immobilized transaminase |
SI2736909T1 (sl) | 2011-07-27 | 2017-08-31 | Farma Grs, D.O.O. | Proces za pripravo sitagliptina in njegovih farmacevtsko sprejemljivih soli |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013065066A1 (en) | 2011-11-02 | 2013-05-10 | Cadila Healthcare Limited | Processes for preparing 4-oxo-4-[3-(trifluoromethyl)-5,6- dihydro [l,2,41-triazolo[43-a]pyrazin-7(8h)-yl]-l-(2,4,5- trifluorophenyl)butan-2-amine |
EP2615080A1 (en) | 2012-01-12 | 2013-07-17 | LEK Pharmaceuticals d.d. | Preparation of Optically Pure ß-Amino Acid Type Active Pharmaceutical Ingredients and Intermediates thereof |
ES2421956B1 (es) | 2012-03-02 | 2014-09-29 | Moehs Ibérica S.L. | Nueva forma cristalina de sulfato de sitagliptina |
CN102702205B (zh) * | 2012-05-16 | 2014-01-15 | 苏州新凯生物医药技术有限公司 | 西他列汀的制备方法 |
EP2674432A1 (en) | 2012-06-14 | 2013-12-18 | LEK Pharmaceuticals d.d. | New synthetic route for the preparation of ß aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha]pyrazin-7-yl compounds |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
CN103319487B (zh) * | 2013-01-10 | 2015-04-01 | 药源药物化学(上海)有限公司 | 西格列汀的制备方法及其中间体 |
EP2961838B1 (en) | 2013-02-28 | 2018-04-18 | Merck Sharp & Dohme Corp. | Immobilized transaminases and process for making and using immobilized transaminase |
WO2014150633A1 (en) | 2013-03-15 | 2014-09-25 | Merck Sharp & Dohme Corp. | Immobilized ketoreductases and process for making and using immobilized ketoreductase |
CN103387577A (zh) * | 2013-07-29 | 2013-11-13 | 迪沙药业集团山东迪沙药业有限公司 | 西格列汀碱的不对称合成方法 |
CN104418861B (zh) | 2013-09-10 | 2017-11-10 | 浙江医药股份有限公司新昌制药厂 | 一种西格列汀的中间体化合物的制备方法 |
CN103923087B (zh) * | 2014-04-21 | 2016-08-31 | 南京靖龙药物研发有限公司 | 一种氘标记西他列汀的制备方法 |
CN105315286B (zh) * | 2014-07-30 | 2018-08-17 | 连云港润众制药有限公司 | 西格列汀的制备 |
CN104387393A (zh) * | 2014-10-31 | 2015-03-04 | 广东东阳光药业有限公司 | 制备西格列汀杂质 |
CA2979033A1 (en) | 2015-03-09 | 2016-09-15 | Intekrin Therapeutics, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
CN106278932B (zh) * | 2015-06-12 | 2020-10-09 | 上海交通大学 | 环状α-脱氢胺基酮、手性环状α-胺基酮及其制备方法 |
CN106607092B (zh) * | 2015-10-22 | 2019-10-08 | 中国石油化工股份有限公司 | 催化剂组合物及其应用 |
CN106607093B (zh) * | 2015-10-22 | 2019-07-09 | 中国石油化工股份有限公司 | 催化剂组合物及其用途 |
ES2638266T3 (es) * | 2015-10-22 | 2017-10-19 | F.I.S.- Fabbrica Italiana Sintetici S.P.A. | Procedimiento mejorado para la preparación de triazol y una de sus sales |
US10047094B1 (en) | 2017-02-10 | 2018-08-14 | F.I.S.—Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of triazole and salt thereof |
CN110996951A (zh) | 2017-04-03 | 2020-04-10 | 科赫罗斯生物科学股份有限公司 | 治疗进行性核上性麻痹的PPARγ激动剂 |
CN109234327A (zh) * | 2017-07-11 | 2019-01-18 | 上海弈柯莱生物医药科技有限公司 | 一种立体选择性的转氨酶在不对称合成手性胺中的应用 |
CN108178761A (zh) * | 2017-12-28 | 2018-06-19 | 安庆奇创药业有限公司 | 一种西格列汀的合成方法 |
CN108929345B (zh) * | 2018-07-18 | 2021-03-19 | 中国人民解放军第四军医大学 | 手性二茂铁双膦配体及其制备方法和应用 |
CN109761988B (zh) * | 2019-01-17 | 2021-07-23 | 深圳市第二人民医院 | 治疗糖尿病的药物西他列汀的制备方法 |
CN112824422B (zh) * | 2019-11-21 | 2023-01-13 | 中国科学院大连化学物理研究所 | 一种手性二茂铁-吲哚双膦配体及其制备方法和其应用 |
CN113636950B (zh) | 2020-05-11 | 2023-01-17 | 浙江医药股份有限公司新昌制药厂 | 一种手性4-芳基-β-氨基酸衍生物的制备方法 |
CN111454272A (zh) * | 2020-06-02 | 2020-07-28 | 雅本化学股份有限公司 | 一种西他列汀的中间体及其合成方法 |
CN114524745A (zh) * | 2022-03-03 | 2022-05-24 | 浙江工业大学 | 一种(R)-N-乙酰基-α-芳基乙胺衍生物的制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0564406B1 (de) * | 1992-04-02 | 1999-05-06 | Novartis AG | Ferrocenyldiphosphine als Liganden für homogene Katalysatoren |
EP0967015B1 (de) * | 1998-06-19 | 2005-01-12 | Degussa AG | Verwendung von Ferrocenylliganden zur katalytischen enantioselektiven Hydrierung |
US6258979B1 (en) * | 1999-11-22 | 2001-07-10 | Henri Kagan | Chiral ferrocene phosphines active in asymmetric catalysis |
DE19956414A1 (de) | 1999-11-24 | 2001-06-13 | Aventis Res & Tech Gmbh & Co | Verfahren zur Herstellung von chiralen Aminen durch homogen katalysierte asymmetrische Hydrierung von Enaminen |
JP4742484B2 (ja) * | 2000-02-22 | 2011-08-10 | ロンザ アーゲー | 3−アミノアルカン酸エステルの製造方法 |
CN1349994A (zh) * | 2000-10-25 | 2002-05-22 | 中国科学院上海有机化学研究所 | 一种具有二茂铁修饰的手性口袋的双膦配体、合成及应用 |
CN1610688A (zh) * | 2000-11-17 | 2005-04-27 | 宾夕法尼亚州研究基金会 | 邻位取代的手性膦和三价膦酸酯及其在不对称催化反应中的用途 |
DE10100971A1 (de) * | 2001-01-11 | 2002-07-18 | Degussa | Verfahren zur Herstellung enantiomerenangereicherter beta-Aminosäure |
UA74912C2 (en) * | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
GB0120167D0 (en) * | 2001-08-17 | 2001-10-10 | Chirotech Technology Ltd | Asymmetric hydrogenation |
EP1386901B1 (en) * | 2002-07-30 | 2015-07-01 | Takasago International Corporation | Method for producing an optically active beta-amino acid |
JP4368632B2 (ja) * | 2002-07-30 | 2009-11-18 | 高砂香料工業株式会社 | 光学活性β−アミノ酸類の製造方法 |
TW200602293A (en) | 2004-04-05 | 2006-01-16 | Merck & Co Inc | Process for the preparation of enantiomerically enriched beta amino acid derivatives |
-
2004
- 2004-03-09 AR ARP040100745A patent/AR043515A1/es active IP Right Grant
- 2004-03-15 DE DE602004014910T patent/DE602004014910D1/de not_active Expired - Lifetime
- 2004-03-15 US US10/549,425 patent/US7468459B2/en active Active
- 2004-03-15 ES ES04720790T patent/ES2307000T3/es not_active Expired - Lifetime
- 2004-03-15 WO PCT/US2004/007793 patent/WO2004085378A1/en active Application Filing
- 2004-03-15 EP EP04720790A patent/EP1606243B1/en not_active Expired - Lifetime
- 2004-03-15 CN CNB2004800073134A patent/CN100339354C/zh not_active Expired - Lifetime
- 2004-03-15 JP JP2006507177A patent/JP4503594B2/ja not_active Expired - Lifetime
- 2004-03-15 CA CA2518435A patent/CA2518435C/en not_active Expired - Lifetime
- 2004-03-15 AT AT04720790T patent/ATE400545T1/de active
- 2004-03-15 AU AU2004223885A patent/AU2004223885B2/en not_active Expired
- 2004-03-18 TW TW093107261A patent/TWI312772B/zh active
-
2009
- 2009-07-08 AU AU2009202775A patent/AU2009202775B2/en not_active Expired
- 2009-07-27 AR ARP090102853A patent/AR072877A2/es not_active Application Discontinuation
-
2010
- 2010-03-05 JP JP2010048680A patent/JP5663176B2/ja not_active Expired - Lifetime
-
2013
- 2013-06-18 JP JP2013127866A patent/JP2013237674A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2004085378A1 (en) | 2004-10-07 |
ATE400545T1 (de) | 2008-07-15 |
CA2518435C (en) | 2010-07-27 |
AR072877A2 (es) | 2010-09-29 |
US7468459B2 (en) | 2008-12-23 |
US20060194977A1 (en) | 2006-08-31 |
TW200510273A (en) | 2005-03-16 |
AU2009202775B2 (en) | 2011-07-28 |
JP4503594B2 (ja) | 2010-07-14 |
JP2010155857A (ja) | 2010-07-15 |
JP2013237674A (ja) | 2013-11-28 |
CA2518435A1 (en) | 2004-10-07 |
AU2009202775A1 (en) | 2009-07-30 |
CN100339354C (zh) | 2007-09-26 |
AU2004223885B2 (en) | 2009-05-14 |
DE602004014910D1 (de) | 2008-08-21 |
ES2307000T3 (es) | 2008-11-16 |
JP5663176B2 (ja) | 2015-02-04 |
JP2006521354A (ja) | 2006-09-21 |
EP1606243B1 (en) | 2008-07-09 |
CN1761642A (zh) | 2006-04-19 |
EP1606243A1 (en) | 2005-12-21 |
AU2004223885A1 (en) | 2004-10-07 |
TWI312772B (en) | 2009-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR043515A1 (es) | Procedimiento para preparar derivados quirales beta aminoacidos mediante hidrogenacion asimetrica | |
Senda et al. | Rhodium-Catalyzed Asymmetric 1, 4-Addition of Organoboron Reagents to 5, 6-Dihydro-2 (1 H)-pyridinones. Asymmetric Synthesis of 4-Aryl-2-piperidinones | |
AR049879A1 (es) | Proceso para la preparacion de derivados de beta aminoacidos enantiomericamente enriquecidos | |
Franklin et al. | Application of the tethered Biginelli reaction for enantioselective synthesis of batzelladine alkaloids. Absolute configuration of the tricyclic guanidine portion of batzelladine B | |
Fukata et al. | Procedure-controlled enantioselectivity switch in organocatalytic 2-oxazolidinone synthesis | |
Diosdado et al. | Catalytic Enantioselective Synthesis of Tertiary Thiols From 5H‐Thiazol‐4‐ones and Nitroolefins: Bifunctional Ureidopeptide‐Based Brønsted Base Catalysis | |
Guo et al. | Highly enantioselective three-component direct mannich reactions of unfunctionalized ketones catalyzed by bifunctional organocatalysts | |
Liu et al. | Asymmetric organocatalytic conjugate addition of dialkyl phosphites to N-unprotected isatylidene malononitriles: access to 3-phospho-2-oxindoles with chiral quaternary stereocenters | |
Duvvuru et al. | Heterocyclic Spiranes and Dispiranes via Enantioselective Phosphine‐Catalyzed [3+ 2] Annulations | |
Liu et al. | Organocatalytic enantioselective conjugate addition of ketones to isatylidine malononitriles | |
AR056203A1 (es) | Derivados de fenil-[1,2,4]-oxadiazol-5-ona con grupo fenilo, un procedimiento para la preparacion de un producto farmaceutico y el uso de este en la profilaxis o tratamiento de trastornos del snc y del metabolismo de la glucosa y de los acidos grasos | |
Wu et al. | Simple and inexpensive threonine-based organocatalysts for the highly diastereo-and enantioselective direct large-scale syn-aldol and anti-Mannich reactions of α-hydroxyacetone | |
Bagi et al. | Resolution of P-stereogenic P-heterocycles via the formation of diastereomeric molecular and coordination complexes (a review) | |
Kawabata et al. | Stereochemical diversity in asymmetric cyclization via memory of chirality | |
Hartley et al. | Absolute configuration of the optical isomers of salbutamol | |
Cabello et al. | Enantioselective addition of aryllithium reagents to aromatic imines mediated by 1, 2-diamine ligands | |
Imae et al. | Ag/ThioClickFerrophos-Catalyzed Enantioselective Mannich Reaction and Amination of Glycine Schiff Base | |
AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
Wu et al. | Simple and inexpensive threonine-based organocatalysts as highly active and recoverable catalysts for large-scale asymmetric direct stoichiometric aldol reactions on water | |
Zhu et al. | α-Oxo-γ-butyrolactam, N-containing pronucleophile in organocatalytic one-pot assembly of butyrolactam-fused indoloquinolizidines | |
AR052871A1 (es) | Una sintesis exo-selectiva de analogos de himbacina | |
Zhuang et al. | Asymmetric synthesis of functionalized dihydronaphthoquinones containing quaternary carbon centers via a metal-free catalytic intramolecular acylcyanation of activated alkenes | |
Silverio et al. | N-Substituted tertiary and O-substituted quaternary carbon stereogenic centers by site-, diastereo-and enantioselective vinylogous Mannich reactions | |
Guang et al. | Organocatalytic enantioselective tandem aldol-cyclization reaction of α-isothiocyanato imides and activated carbonyl compounds | |
US20150105552A1 (en) | Synthesis of chiral enaminones, their derivatives, and bioactivity studies thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure | ||
FA | Abandonment or withdrawal | ||
FG | Grant, registration |